Clinical Trial Update: Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating docetaxel with radiation therapy for stage II-IV cervical cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: University of Miami | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: WITHDRAWN